Stay updated on SHP2 Inhibitor BBP-398 Clinical Trial
Sign up to get notified when there's something new on the SHP2 Inhibitor BBP-398 Clinical Trial page.

Latest updates to the SHP2 Inhibitor BBP-398 Clinical Trial page
- Check5 days agoChange DetectedThe page's Revision value changed from v3.5.3 to v3.5.4, reflecting a small maintenance/update to the page's backend or documentation. No substantive content or functionality appears to be affected.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA new page revision v3.5.3 was published, replacing the previous v3.5.2. This is a metadata/version update and does not alter the study details displayed on the page.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision tag updated to v3.5.2; the previous tag was v3.5.0.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check69 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check98 days agoChange DetectedAdded Revision: v3.4.2. The old 3.4.1 notice and the government funding lapse notice have been removed.SummaryDifference0.5%

Stay in the know with updates to SHP2 Inhibitor BBP-398 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SHP2 Inhibitor BBP-398 Clinical Trial page.